Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis

British Journal of Cancer

Volumn 80, Issue 11, 1999, Pages 1682-1688

  Hilakivi Clarke, L ^a,b   Onojafe, I ^a   Raygada, M ^a,b   Cho, E ^a,c   Skaar, T ^a,c   Russo, I ^d   Clarke, R ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Genistein; Mammary tumorigenesis; Prepuberty; Zearalenone

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; GENISTEIN; PHYTOESTROGEN; ZEARALENONE;

ADENOCARCINOMA; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER PREVENTION; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; MALIGNANT TRANSFORMATION; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; CELL DIVISION; FEMALE; GENISTEIN; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; SEXUAL MATURATION; TIME FACTORS; WEIGHT GAIN; ZEARALENONE;

EID: 0032774109     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690584     Document Type: Article

References (62)

1. Akivama T, Ishida J, Nakagawa S, Oguwu H, Watanabe S, Itou N, Shibata M and Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 262: 5592-5595
2. Barnes S (1997) The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat 46: 169-179
3. Bern HA, Mills KT and Edery M (1985) Estrogen-associated defects in rodent mammary gland development. In: Estrogens in the Environment, McLachlan JA (ed), pp. 319-326 Elsevier; Amsterdam
4. Burgess LW, Nelson PE and Toussoun TA (1982) Characterization, geographic distribution and ecology of Fusarium crookwellense sp. nov. Trans Br Mycot Soc 79: 497-505
5. Clark GM and McGuire WL (1988) Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 15: 20-25
6. Clarke K (1997) Issues in experimental design and analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat 46: 255-278
7. Clarke R, Dickson RB and Lippman ME (1992) Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. Crit Rev Oncol Hematol 12: 1-23
8. Collins BM, McLachlan JA and Arnold SF (1997) The estrogenic and antiestrogeneic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steriods 62: 365-372
9. Ekhom A, Trichopoulos D, Adami HO, Hsich CC and Lan SJ (1992) Evidence of prenatal influences on breast cancer risk. Lancet 340: 1015-1018
10. Faber KA and Hughes CLJ (1991) The effect of neonatal exposure to diethylstilbestrol, genistein, and zearalenone on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat. Biol Reprod 45: 649-653
11. Freireich EJ, Gehan EA, Rall DP, Schmidt LH and Skipper HE (1966) Quantitative comparison of toxicity of unticancer agents in the mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep 50: 219-244
12. Fukutake M, Takahashi M, Ishida K, Kawamura H, Sugimura T and Wakahayashi K (1996) Quantification of genistein and genistin in soybeans and soybean products. Food Chem Toxicol 34; 457-461
13. Gotoh T, Yamada K, Yin H, Ito A, Kataoka T and Dohi K (1998) Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res 89: 137-142
14. Grodstein E, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH and Speizer FE (1997) Postmenopausal hormone therapy and mortality. N Eng J Med 336: I769-1775
15. Grubbs CJ, Farneli DR, Hill DL and McDonough KC (1985) Chemoprevention of n-nitro-n-methylurea-induced mammary cancers by pretreatment will 17beta-estradiol and progesterone. J Natl Cancer Inst 74: 927-931
16. Hagler WM, Tyczkowska K and Hamilton PB (1984) Simultaneous occurrence of deoxynivalenol, zearalenone, and aflatoxin in 1982 scabby wheat from the Midwestern United States. Appl Environ Microbiol 47: 151-154
17. Hanfelt JJ (1997) Statistical approaches to experimental design and data analysis of in vivo studies. Breast Cancer Res Treat 46: 279-302
18. Harding C, Tetlow L, McMichael Phillips D, Osundeko O, Potten CS and Bundred NJ (1997) Oestrogenic effects of soy on nipple aspirate fluid. Breast Cancer Res Treat 46: 80-Abstract
19. Haslam SZ (1988) Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122: 464-470
20. Haslam S (1989) The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. Endocrinology 125: 2766-2772
21. Hawrylewiez EJ, Huang HH and Blair WH (1991) Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 121: 1693-1698
22. Hilakivi-Clarke L, Cho E, Raygada M and Kenney N (1997a) Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182, 780. J Cell Physiol 170: 279-289
23. Hilakivi Clarke L, Clarke R, Onojafe I, Raygada M, Cho E and Lippman ME (1997b) A maternal diet high in n 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 94: 9372-9377
24. Hilakivi Clarke LA, Raygada M, Stoica A and Martin M-B (1998) Consumption of a high fat diet during pregnancy alters estrogen receptor content, protein kinase C activity and morphology of mammary gland in the mother and her female offspring, Cancer Res 58; 654-660
25. Hirohata T, Shigematsu T, Nomura AMY, Nomura Y, Horie A and Hirohata I (1985) Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr 69; 187-190
26. Hsieh CY, Santell RC, Haslam SZ and Helferich WG (1998) Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58; 3833-3838
27. Ingram D, Sanders K, Kolybaba M and Lopez D (1997) Case-control study of phytoestrogens and breast cancer. Lancet 350: 990-994
28. Kuiper Goodman T (1990) Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. Can J Physiol Pharm 68: 1017-1024
29. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J and Day NE (1991) Dietary effects on breast cancer risk in Singapore. Lancet 337: 1197-1200
30. Lopez J, Ogren L, Verjan R and Talamantes F (1988) Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice. Teratology 38: 129-134
31. Lu LJ, Broemeling I., Marshall M and Ramanujam VM (1995) A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption. Cancer Epidemiol Biomarkers Prev 4; 497-503
32. Luo Y, Yoshizawa T and Katayama T (1990) Comparative study on the natural occurrenee of fusarium mycotoxins (trichothecenes and zearalenone) in com and wheat from high-and low-risk areas for human esopnageal cancer in China, Appl Environ Microbiol 56: 3723-3726
33. McMichael-Phillips DF, Harding C Morton M, Roberts SA, Howell A, Potten CS and Bundled NJ (1998) Effect of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 68 (suppl). 1431S-1436S
34. Martin PM, Horwitz KB, Ryan DS and McGuire W (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103: 1860-1867
35. Messina M, Persky V, Setchell KDR and Barnes S (1994) Soy intake and breast cancer: a review of the in vitro and in vivo data. Nutr Cancer 21: 113-131
36. Michels KB, Triehopoulos D, Robins JM, Rosner BA, Manson JE, Hunter D, Colditz GA, Hankinson SE. Speizer FE and Willett WC (1996) Birth weight as a risk factor for breast cancer. Lancet 348: 1542-1546
37. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S and Lamartiniere CA (1996) Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457
38. Nagasawa H, Yanai R, Shondo M, Nakumura T and Tanabe Y (1974) Effect of neonalnlly administered estrogen and prolactin on normal and neoplastic mammary growth and serum estradiol-17 level in rats. Cancer Res 34: 2643-2646
39. Nelson J, Clarke R, Dickson GR, Van Den Berg HW and Murphy RE (1986) The effects of Mg2+ ions or EDTA on nuclear integrity and apparent subcellular distribution of unoccupied oestrogen receptors in breast cancer cells. J Steroid Biochem 25: 619-626
40. Nomura A, Henderson BE and Lee J (1978) Breast cancer and diet among the Japanese in Hawaii, Am J Clin Nutr 31: 2020-2025
41. Petrakis NL, Barnes S, King EB, Lowenstein J, Wieneke J, Lee MM, Miike R, Kirk M and Coward I. (1996) Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. Cancer Epidemiol Biomark Prev 5: 785-794
42. Ralston AT (1978) Effect of zearalanol on weaning weight of male calves. J Anim Sci 47: 1203-1206
43. Russo IH, Medado J and Russo J (1994) Endocrine influences on the mammary gland. In Integament and Mammary Glands. Eds TC Jones, U Mohr & RD Hunt. Berlin: Springer-Verlag, pp. 252-266
44. Russo J and Russo IH (1987) Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112-137
45. Sanderson M, Williams M, Malone KE, Stanford JL, Emanuel I, While E and Daling JR (1996) Perinatal factors and risk of breast cancer. Epidemiology 7: 34-37
46. Santell RC, Chang YC, Nair MG and Helferich WG (1997) Dietary genistein exerts estrogencic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 127: 263-269
47. Schoental R (1974) Role of podophyllotoxin in the bedding and dietary zearalenone on incidence of 'spontaneous' tumors in laboratory animals. Cancer Res 34: 2419
48. Schoental K (1985) Trichothecenes, zearalenone, and other carcinogenic metabolites of fusarium and related microfungi. Adv Cancer Res 45: 217-290
49. Scow A, Shi C-Y, Franke A, Hunkin JH, Lee HP and Yu MC (1998) Isoflavoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 7: 133-140
50. Setchell KDK, Borriello SP, Hulme P, Kirk DN and Axelson M (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40: 569-578
51. Snedecor GW (1988) Statistical Methods, 8th Edn. Iowa State University Press: Arnes, Iowa
52. Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S and Talamantes F (1995) Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 16: 2847-2853
53. Verhoeven G, Vandoren G, Heyns W, Kuhn ER, Janssens JP, Teuwen D, Goddeeris E, Lesaffre E and DeMoor P (1982) Incidence, growth and estradiol-receptor levels of 7,12-dimethylbenz(alpha)antracene-induced mammary tumours in rats: effects of neonatal sex steroids and oestradiol implants. J Endocrinol 95: 357-368
54. Wang TT, Sathyamoorthy N and Phang JM (1996) Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271-275
55. Wiggins JP, Rothenbacher H, Wilson LL, Martin RJ, Wangness PJ and Ziegler JH (1979) Growth and endocrine responses of lambs to zearanol implants: effects of preimplant growth rate and breed of sire. J Anim Sci 49: 291-297
56. Winstanley J, Cooke T, George WD, Murray G, Holt S, Croton R, Griffiths K and Nicholson R (1991) The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer 64: 99-101
57. Witte JS, Ursin G, Siemiatyeki J, Thompson WD, Paganini-Hill A and Haile RW (1997) Diet and premenopausal bilateral breast cancer: A case-control study. Breast Cancer Res Treat 42: 243-251
58. Wu AH, Ziegler RG, Horn-Koss PL, Nomura AMY, West DW, Kotonel LN, Rosenthal IF, Hoover RN and Pike MC (1996) Totu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5: 901-906
59. Wu AH, Ziegler RG, Nomura AMY, West DW, Kolonel LN, Horn-Ross PL, Hoover RN and Pike MC (1998) Soy intake and risk of breast cancer in Asians and Asian-Americans. Am J Clin Nutr 68 (Suppl). 1437S-1443S
60. Yuan JM, Wang QS, Ross RK, Henderson BF, and Yu MC (1995) Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71: 1353-1358
61. Zava DT and Duwe G (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27; 31-40
62. Zheng W, Dai Q, Cluster LJ, Shu XO, Wen WQ, Jin F and Franke AA (1999) Urinary exeretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8: 35-40